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Materials and Methods 
ACE gene I/D polymorphism analysis 
High molecular weight genomic DNA was prepared from EDTA-collected venous blood 
samples (10-20 ml) using a Cyclo-Prep™ Genomic DNA Isolation Kit (Genetix Biotech 
Asia, New Delhi, India) according to the manufacturer’s instructions and was stored in 
Tris-EDTA buffer (pH 8.0) at -20°C. Genomic DNA was subjected to PCR amplification 
using oligonucleotide primers 5’-CTGGAGACCACTCCCATCCTTTCT-3 (forward) and 
5’-GATGTGGCCATCACATTCGTCAGAT-3’ (reverse) (Eurofins Genomics, Bangalore, 
India) in order to amplify the I/D polymorphic 287-base pair repetitive sequence 
(rs1799752) in intron 16 of the ACE gene (Reference sequence AF118569, repeat 
region 14094-14381; National Center for Biotechnology Information, Bethesda, MD, 
USA). 
 
PCR amplifications were performed on 100 ng of genomic DNA in 25-l reactions 
containing: 0.5 units of TaqI DNA polymerase (Chromos Biotech, Bengaluru, India), 1 
µM of each primer, 0.2 mM of each deoxynucleotide triphosphate (dATP, dCTP, dGTP 
and dTTP) (Chromos Biotech), 1.5 mM magnesium chloride (Chromos Biotech) and 0.2 
volumes of 5x buffer (50 mM Tris-hydrochloride, pH 8.5; 0.05% (w/v) gelatin; 250 mM 
potassium chloride; 0.5% (v/v) Tween 20; and 0.5% (v/v) Nonidet P-40) (Chromos 
Biotech). The PCR amplifications were performed in an Eppendorf Mastercycler® 
gradient thermo cycler (Eppendorf North America, Inc., Hauppauge, NY, USA) under 
the following conditions: initial denaturation at 95°C for 5 min; 30 cycles of amplification 
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at 94°C for 1 min, 58°C for 1 min and 72°C for 1 min; and a final extension at 72°C for 7 
min. 
 
PCR amplification products were analysed in 1.5% (w/v) agarose gels along with pUC 
Mix Marker 8 DNA fragment size markers (Thermo Fisher Scientific Inc., Waltham, MA, 
USA). Following staining with ethidium bromide, gels were visualised under UV light 
and genotyped according to the following pattern: the presence of a single PCR 
amplification product of 480 base pairs represented an I/I homozygous individual, the 
presence of a single PCR amplification product of 193 base pairs represented a D/D 
homozygous individual, and the presence of both PCR amplification products 
represented a I/D heterozygous individual. The accuracy of the genotyping protocol 
was verified by repeating the PCR analysis on 20 randomly selected DNA samples. All 
initial results were verified by this re-analysis. 
 
Enzyme-linked immunosorbent assay for serum ACE level measurement 
Venous blood samples (10-20 ml) were collected from patients and controls, serum 
prepared and stored at -80°C until required. Enzyme-linked immunosorbent assay 
(ELISA) kits for measuring serum ACE levels in patient and control sera were 
purchased from Bio Vendor-Laboratoni Medicina a.s (Brno, Czech Republic) and used 
according to the manufacturer’s protocol. Sera were analysed in triplicate in two 
experiments, and ACE levels were reported as pg/ml. Intra- and inter-assay coefficients 
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Statistical analysis was carried out using GraphPad InStat 3 software (GraphPad 
Software Inc., La Jolla, CA, USA). The frequencies of the ACE I/D genotypes and 
alleles in SLE patient and control groups were compared using the Chi-square test with 
Yate’s correction for contingency tables. Odds ratios with 95% confidence intervals 
were calculated according to a previous method (1). Expected genotype counts were 
calculated according to the Hardy-Weinberg equilibrium (2), and compared with 
observed genotypes in the Chi-square test. Comparison of continuous variables was 
carried out using Mann-Whitney or Kruskal-Wallis tests, as appropriate. Bonferroni-
adjusted P values were calculated for multiple comparisons of variables. Spearman’s 
rank (r) correlation test was used to measure the statistical dependence between two 
variables. In all tests, P values (two-tailed) < 0.05 were regarded as significant. 
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Supplementary Table 1. Clinical details of SLE patients included in the study 
 
 
aDisease activity was assessed using the SLE disease activity index (SLEDAI) (3). 
bHistological findings in renal biopsies were classified according to the International Society 






Number (%) of SLE patients or detail 
of SLE patient group 
 
Mean age at SLE onset ± SD 25.7 ± 9.2 years (range 11-67 years) 




Mean SLEDAI  ± SD 
SLEDAI 1-8  
SLEDAI 9-18 
SLEDAI > 18  
 























Organic brain syndrome; cranial nerve disorder; lupus 
headache; new onset of cerebrovascular accident(s) 
excluding arteriosclerosis 

































Class I, Minimal mesangial lupus nephritis  
Class II, Mesangial proliferative lupus nephritis  
Class III, Focal lupus nephritis 
Class IV, Diffuse lupus nephritis  
Class V, Membranous lupus nephritis  
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